呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

急诊成人经鼻高流量氧疗临床应用专家共识

2021-09-10 中国医师协会急诊医师分会 中国急救医学. 2021,41(09)

经鼻高流量氧疗

经鼻高流量氧疗（high-flow nasal cannula oxygen therapy,HFNC）是一种通过无需密封的导管经鼻输入经过加温湿化的高流量混合气体的呼吸治疗方法。大量研究表明,HFN

中文标题：

急诊成人经鼻高流量氧疗临床应用专家共识

发布机构：

中国医师协会急诊医师分会

发布日期：

2021-09-10

简要介绍：

经鼻高流量氧疗（high-flow nasal cannula oxygen therapy,HFNC）是一种通过无需密封的导管经鼻输入经过加温湿化的高流量混合气体的呼吸治疗方法。大量研究表明,HFNC可有效缓解呼吸困难,对轻中度呼吸衰竭有良好的临床疗效,且操作简便,具有良好的患者耐受性,临床应用越来越广泛。

相关资料下载：
[AttachmentFileName(sort=1, fileName=急诊成人经鼻高流量氧疗临床应用专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0de3d1c00218853d, title=急诊成人经鼻高流量氧疗临床应用专家共识, enTitle=, guiderFrom=中国急救医学. 2021,41(09), authorId=0, author=, summary=经鼻高流量氧疗（high-flow nasal cannula oxygen therapy,HFNC）是一种通过无需密封的导管经鼻输入经过加温湿化的高流量混合气体的呼吸治疗方法。大量研究表明,HFN, cover=https://img.medsci.cn/2021917/1631891750288_2020535.jpg, journalId=0, articlesId=null, associationId=327, associationName=中国医师协会急诊医师分会, associationIntro=急诊科医师分会成立将推动急诊发展,为抢救患者生命，维护人民健康做出更大贡献,分会将就急诊科自身建设、行业发展、自律维权、科研合作、文化建设等问题展开工作，把分会建成为急诊科医师温馨家园！, copyright=0, guiderPublishedTime=Fri Sep 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">经鼻高流量氧疗（high-flow nasal cannula oxygen therapy,HFNC）是一种通过无需密封的导管经鼻输入经过加温湿化的高流量混合气体的呼吸治疗方法。大量研究表明,HFNC可有效缓解呼吸困难,对轻中度呼吸衰竭有良好的临床疗效,且操作简便,具有良好的患者耐受性,临床应用越来越广泛。</span></p>, tagList=[TagDto(tagId=100102, tagName=经鼻高流量氧疗)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=100102, guiderKeyword=经鼻高流量氧疗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=20086, appHits=618, showAppHits=0, pcHits=1819, showPcHits=19457, likes=0, shares=55, comments=36, approvalStatus=1, publishedTime=Fri Sep 17 23:18:50 CST 2021, publishedTimeString=2021-09-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Fri Sep 17 23:16:00 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 10:49:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=急诊成人经鼻高流量氧疗临床应用专家共识.pdf)])
急诊成人经鼻高流量氧疗临床应用专家共识.pdf
下载请点击：
评论区 (30)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1205490, encodeId=8d521205490c1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Thu Mar 24 09:59:15 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197012, encodeId=d7e9119e012a9, content=有了急诊的，其他领域也可以拓展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kCVDFR5ch32wWsNjTTbLPFWib8EHlpWgkTrTrDQF6FLtq3oGQMZN3ad8wGKJJ4s6Q37d7na0qJG2hufs4YX87Dw/132, createdBy=13085307820, createdName=柳叶扳手, createdTime=Thu Feb 24 21:41:47 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196563, encodeId=237a119656378, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae742540399, createdName=1251df21m40暂无昵称, createdTime=Wed Feb 23 21:34:28 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196368, encodeId=b743119636822, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Wed Feb 23 11:38:00 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196096, encodeId=1dc51196096b5, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:15:03 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-03-24 医路前行4231

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1205490, encodeId=8d521205490c1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Thu Mar 24 09:59:15 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197012, encodeId=d7e9119e012a9, content=有了急诊的，其他领域也可以拓展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kCVDFR5ch32wWsNjTTbLPFWib8EHlpWgkTrTrDQF6FLtq3oGQMZN3ad8wGKJJ4s6Q37d7na0qJG2hufs4YX87Dw/132, createdBy=13085307820, createdName=柳叶扳手, createdTime=Thu Feb 24 21:41:47 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196563, encodeId=237a119656378, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae742540399, createdName=1251df21m40暂无昵称, createdTime=Wed Feb 23 21:34:28 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196368, encodeId=b743119636822, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Wed Feb 23 11:38:00 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196096, encodeId=1dc51196096b5, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:15:03 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-24 柳叶扳手

    有了急诊的，其他领域也可以拓展

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1205490, encodeId=8d521205490c1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Thu Mar 24 09:59:15 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197012, encodeId=d7e9119e012a9, content=有了急诊的，其他领域也可以拓展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kCVDFR5ch32wWsNjTTbLPFWib8EHlpWgkTrTrDQF6FLtq3oGQMZN3ad8wGKJJ4s6Q37d7na0qJG2hufs4YX87Dw/132, createdBy=13085307820, createdName=柳叶扳手, createdTime=Thu Feb 24 21:41:47 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196563, encodeId=237a119656378, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae742540399, createdName=1251df21m40暂无昵称, createdTime=Wed Feb 23 21:34:28 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196368, encodeId=b743119636822, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Wed Feb 23 11:38:00 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196096, encodeId=1dc51196096b5, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:15:03 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-23 1251df21m40暂无昵称

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1205490, encodeId=8d521205490c1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Thu Mar 24 09:59:15 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197012, encodeId=d7e9119e012a9, content=有了急诊的，其他领域也可以拓展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kCVDFR5ch32wWsNjTTbLPFWib8EHlpWgkTrTrDQF6FLtq3oGQMZN3ad8wGKJJ4s6Q37d7na0qJG2hufs4YX87Dw/132, createdBy=13085307820, createdName=柳叶扳手, createdTime=Thu Feb 24 21:41:47 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196563, encodeId=237a119656378, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae742540399, createdName=1251df21m40暂无昵称, createdTime=Wed Feb 23 21:34:28 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196368, encodeId=b743119636822, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Wed Feb 23 11:38:00 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196096, encodeId=1dc51196096b5, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:15:03 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-23 ANNA1

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1205490, encodeId=8d521205490c1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Thu Mar 24 09:59:15 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197012, encodeId=d7e9119e012a9, content=有了急诊的，其他领域也可以拓展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kCVDFR5ch32wWsNjTTbLPFWib8EHlpWgkTrTrDQF6FLtq3oGQMZN3ad8wGKJJ4s6Q37d7na0qJG2hufs4YX87Dw/132, createdBy=13085307820, createdName=柳叶扳手, createdTime=Thu Feb 24 21:41:47 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196563, encodeId=237a119656378, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae742540399, createdName=1251df21m40暂无昵称, createdTime=Wed Feb 23 21:34:28 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196368, encodeId=b743119636822, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Wed Feb 23 11:38:00 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196096, encodeId=1dc51196096b5, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:15:03 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-22 ms2000001545439177

    受益匪浅

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

新型冠状病毒肺炎患者经鼻高流量氧疗使用管理专家共识

中华医学会呼吸病学分会 · 2020-02-19

拓展阅读

新型冠状病毒肺炎患者经鼻高流量氧疗使用管理专家共识

中华医学会呼吸病学分会 · 2020-02-19

急性呼吸道传染病患者经鼻高流量氧疗期间医院感染防控的最佳证据总结

浙江大学医学院附属第四医院医院感染管理科 · 2023-03-10

新生儿经鼻高流量氧疗指南（2022）-英文版

中国医师协会新生儿科医师分会 · 2023-09-06

经鼻高流量氧疗临床麻醉规范应用专家共识(2023版)

暂未更新 · 2023-08-15